Intelligent Bio Solutions, Inc. (INBS)
2.50
-0.01
(-0.40%)
USD |
NASDAQ |
Aug 24, 16:00
2.33
-0.17
(-6.80%)
After-Hours: 20:00
Intelligent Bio Solutions Enterprise Value : 4.871M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.871M |
| August 21, 2026 | 4.90M |
| August 20, 2026 | 5.307M |
| August 19, 2026 | 5.365M |
| August 18, 2026 | 6.963M |
| August 17, 2026 | 7.399M |
| August 14, 2026 | 5.655M |
| August 13, 2026 | 6.324M |
| August 12, 2026 | 4.987M |
| August 11, 2026 | 3.563M |
| August 10, 2026 | 3.302M |
| August 07, 2026 | 3.36M |
| August 06, 2026 | 3.389M |
| August 05, 2026 | 2.808M |
| August 04, 2026 | 2.866M |
| August 03, 2026 | 2.895M |
| July 31, 2026 | 2.866M |
| July 30, 2026 | 2.183M |
| July 29, 2026 | 2.111M |
| July 28, 2026 | 2.238M |
| July 27, 2026 | 2.604M |
| July 24, 2026 | 2.692M |
| July 23, 2026 | 2.866M |
| July 22, 2026 | 2.837M |
| July 21, 2026 | 2.866M |
| Date | Value |
|---|---|
| July 20, 2026 | 3.331M |
| July 17, 2026 | 3.741M |
| July 16, 2026 | 3.999M |
| July 15, 2026 | 4.261M |
| July 14, 2026 | 4.144M |
| July 13, 2026 | 4.290M |
| July 10, 2026 | 3.883M |
| July 09, 2026 | 4.028M |
| July 08, 2026 | 3.912M |
| July 07, 2026 | 4.086M |
| July 06, 2026 | 4.232M |
| July 02, 2026 | 4.115M |
| July 01, 2026 | 4.086M |
| June 30, 2026 | 4.275M |
| June 29, 2026 | -0.7813M |
| June 26, 2026 | -0.7213M |
| June 25, 2026 | -0.9214M |
| June 24, 2026 | -0.8214M |
| June 23, 2026 | -0.6312M |
| June 22, 2026 | -0.4611M |
| June 18, 2026 | -0.6413M |
| June 17, 2026 | -0.7213M |
| June 16, 2026 | -0.6212M |
| June 15, 2026 | -0.5612M |
| June 12, 2026 | -0.4211M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanara MedTech, Inc. | 349.17M |
| Anteris Technologies Global Corp. | 603.44M |
| 20/20 Biolabs, Inc. | 3.914M |
| Quest Diagnostics, Inc. | 32.97B |
| Labcorp Holdings, Inc. | 34.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.917M |
| Revenue (Quarterly) | 1.146M |
| Total Expenses (Quarterly) | 5.054M |
| EPS Diluted (Quarterly) | -1.345 |
| Gross Profit Margin (Quarterly) | 21.68% |
| Profit Margin (Quarterly) | -341.9% |
| Earnings Yield | -377.9% |
| Normalized Earnings Yield | -368.35 |